View Item 

Show simple item record

Administration of Insulin by Continuous Ambulatory Peritoneal Dialysis
dc.contributor.authorChan, Edwinaen_US
dc.contributor.authorMontgomery, Patricia A.en_US
dc.date.accessioned2012-03-16T16:00:42Z
dc.date.available2012-03-16T16:00:42Z
dc.date.issued1993-09-10en_US
dc.identifier.citationChan, Edwina; Montgomery, Patricia A. (1993). "Administration of Insulin by Continuous Ambulatory Peritoneal Dialysis." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 13(5). <http://hdl.handle.net/2027.42/90356>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90356
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleAdministration of Insulin by Continuous Ambulatory Peritoneal Dialysisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacy Services, University of Michigan Medical Centeren_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, Ann Arbor, Michiganen_US
dc.identifier.pmid8247911en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90356/1/j.1875-9114.1993.tb04306.x.pdf
dc.identifier.doi10.1002/j.1875-9114.1993.tb04306.xen_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceAmair P, Khanna R, Leibel B et al. Continuous ambulatory peritoneal dialysis in diabetics with end‐stage renal disease. N Engl J Med 1982; 306: 625 – 30.en_US
dc.identifier.citedreferenceBalducci A, Slama G, Rottenbourg J et al. Intraperitoneal insulin in uremic diabetics undergoing continuous ambulatory peritoneal dialysis. Br Med J 1981; 283: 1021 – 3.en_US
dc.identifier.citedreferenceRottembourg J, Shahat, EI Y, Agrafiotis A et al. Continuous ambulatory peritoneal dialysis in insulin‐dependent diabetic patients: a 40‐month experience. Kidney Int 1983; 23: 40 – 5.en_US
dc.identifier.citedreferenceMactier RA, Moore H, Khanna R et al. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats. Nephron 1990; 54: 2404.en_US
dc.identifier.citedreferenceHenderson IS, Patterson KR, Leung ACT. Decreased intraperitoneal insulin requirements during peritonitis on continuous ambulatory peritoneal dialysis. Br Med J 1985; 290: 1474.en_US
dc.identifier.citedreferenceRubin J, Reed V, Adair C et al. Effect of intraperitoneal insulin on solute kinetics in CAPD: insulin kinetics in CAPD. Am J Med Sci 1986; 291: 81 – 7.en_US
dc.identifier.citedreferenceKane M, Jay M, DeLuca PP. Binding of insulin to a continuous ambulatory peritoneal dialysis system. Am J Hosp Pharm 1986; 43: 81 – 8.en_US
dc.identifier.citedreferenceJohnson CA, Amidon G, Reichert JE et al. Adsorption of insulin to the surface of peritoneal dialysis solution containers. Am J Kidney Dis 1983; 3: 224 – 8.en_US
dc.identifier.citedreferenceTwardowski ZJ, Nolph KD, McGray TJ et al. Influence of temperature and time on insulin adsorption to plastic bags. Am J Hosp Pharm 1983; 40: 583 – 6.en_US
dc.identifier.citedreferenceCohen IM, Lee S. Diabetes, intraperitoneal insulin, and CAPD. Clin Exp Dial Apheresis 1981; 5: 269 – 75.en_US
dc.identifier.citedreferenceDolgos ET, Vidt DG, Schumacher OP et al. Plasma insulin and glucose levels in diabetic patients undergoing continuous ambulatory peritoneal dialysis using insulin only in the dialysate. Cleve Clin Q 1984; 51: 611 – 14.en_US
dc.identifier.citedreferenceSpotti D, Slaviero G, La Rocca E et al. Intermediary metabolism and glycemic control in insulin‐dependent diabetic uremic patients treated by continuous peritoneal dialysis. Nephron 1988; 49: 219 – 22.en_US
dc.identifier.citedreferenceAmatruda JM, Salhanick AI. Insulin and steatonecrosis: are they related? [abstr] Hepatology 1989; 10: 1024 – 5.en_US
dc.identifier.citedreferenceWanless IR, Bargman JM, Oreopoulos DG et al. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 1989; 2: 69 – 74.en_US
dc.identifier.citedreferenceKrothapalli R, Patel HS, Lacke C et al. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure. South Med J 1983; 76: 521 – 4.en_US
dc.identifier.citedreferenceSmythe M, Malouf E. Visual compatibility of insulin with secondary intravenous drugs in admixtures. Am J Hosp Pharm 1991; 48: 125 – 6.en_US
dc.identifier.citedreferenceSewell DL, Thomas AG, Brown SD et al. Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin. Am J Kidney Dis 1983; 3: 209 – 12.en_US
dc.identifier.citedreferenceFriedman EA. Diabetic renal disease. In: Rifkin H, Porte D, eds. Diabetes mellitus: theory and practice. New York: Elsevier, 1991: 684 – 709.en_US
dc.identifier.citedreferenceSutherland DER, Morrow CE, Fryd DS et al. Transplantation 1982; 34: 319 – 25.en_US
dc.identifier.citedreferenceMactier RA, Khanna R. Intraperitoneal insulin in diabetic CAPD patients. Int J Artif Organs 1988; 11: 9 – 12.en_US
dc.identifier.citedreferenceGalloway JA, Spradlin CT, Howey DC, Dupre J. Intrasubject differences in pharmacodynamic responses: the immutable problem of present‐day treatment? In: Serrano‐Ruis M, LeFebvre J, eds. Diabetes 1985. New York: Elsevier, 1986: 877 – 86.en_US
dc.identifier.citedreferenceBinder C, Lauritzen T, Faber O, Pramming S. Insulin pharmacokinetics. Diabetes Care 1984; 7: 188 – 99.en_US
dc.identifier.citedreferenceZinman B. The physiologic replacement of insulin. N Engl J Med 1989; 321: 363 – 70.en_US
dc.identifier.citedreferenceNelson JA, Stephen R, Landau ST et al. Intraperitoneal insulin administration produces a positive portal‐systemic blood insulin gradient in unanesthetized unrestrained swine. Metabolism 1982; 31: 969 – 72.en_US
dc.identifier.citedreferenceMicossi P, Cristallo M, Librenti C et al. Free insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administration. Diabetes Care 1986; 9: 575 – 8.en_US
dc.identifier.citedreferenceJarrett RJ. Is insulin atherogenic? [editorial] Diabetologia 1988; 31: 71 – 5.en_US
dc.identifier.citedreferenceZavaroni I, Bonora E, Pagliara M et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702 – 6.en_US
dc.identifier.citedreferenceStout RW. Overview of the association between insulin and atherosclerosis. Metabolism 1985; 34 ( suppl 1 ): 7 – 12.en_US
dc.identifier.citedreferenceO'Brien M, Mason NA. Systemic absorption of intraperitoneal antibiotic in CAPD. Clin Pharm 1992; 11: 246 – 54.en_US
dc.identifier.citedreferenceGreenwood RH, Davies CJ, Senator GB, O'Brien I, Hayes TM. The transport of peptide hormones across the peritoneal membrane in man. Clin Sci 1979; 57: 28 – 9.en_US
dc.identifier.citedreferenceShapiro DJ, Blumenkrantz MJ, Levin SR et al. Absorption and action of insulin added to peritoneal dialysate in dogs. Nephron 1979; 23: 174 – 80.en_US
dc.identifier.citedreferenceWideroe T, Smeby LC, Berg KJ et al. Intraperitoneal ( 125 I) insulin absorption during intermittent and continuous peritoneal dialysis. Kidney Int 1983; 23: 22 – 8.en_US
dc.identifier.citedreferenceSchade DS, Eaton RP, Davis T et al. The kinetics of peritoneal insulin absorption. Metabolism 1981; 30: 149 – 55.en_US
dc.identifier.citedreferenceSchade DS, Eaton RP, Spencer W et al. The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system. Metabolism 1979; 28: 195 – 7.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1875-9114.1993.tb04306.x.pdf
Size:
612.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.